Larimar Therapeutics, Inc. Common Stock LRMR
$3.14
-0.95%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $11.86
- Implied Upside
- +277.6%
- Price Target Range
- $5.00 – $21.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-14 | Leerink PartnersJoseph Schwartz |
Assumes | Outperform | $13 |
| 2026-08-05 | WedbushLaura Chico |
Maintains | Outperform | $12 → $11 |
| 2026-07-02 | HC Wainwright & Co.Raghuram Selvaraju |
Assumes | Buy | $10 |
| 2026-06-30 | BairdJoel Beatty |
Maintains | Outperform | $7 → $5 |
| 2026-05-27 | JP MorganTessa Romero |
Initiates coverage on | Overweight | $9 |
| 2026-05-18 | WedbushLaura Chico |
Maintains | Outperform | $13 → $12 |
| 2026-03-20 | WedbushLaura Chico |
Maintains | Outperform | $12 → $13 |
| 2026-03-03 | WedbushLaura Chico |
Maintains | Outperform | $11 → $12 |
| 2026-02-25 | CitigroupSamantha Semenkow |
Maintains | Buy | $12 → $14 |
| 2026-02-25 | WedbushLaura Chico |
Reiterates | Outperform | $11 |
| 2025-10-02 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $26 → $21 |
| 2025-09-30 | WedbushLaura Chico |
Maintains | Outperform | $15 → $11 |
| 2025-09-30 | BairdJoel Beatty |
Maintains | Outperform | $10 → $7 |
| 2025-08-19 | JMP SecuritiesJonathan Wolleben |
Reiterates | Market outperform | $18 |
| 2025-08-15 | JMP SecuritiesJonathan Wolleben |
Maintains | Market outperform | $22 → $18 |
| 2025-06-25 | GuggenheimYatin Suneja |
Reiterates | Buy | $26 |
| 2025-06-24 | WedbushLaura Chico |
Maintains | Outperform | $17 → $15 |
| 2025-06-24 | GuggenheimYatin Suneja |
Reiterates | Buy | $26 |
| 2025-03-25 | GuggenheimYatin Suneja |
Reiterates | Buy | $26 |
| 2025-03-25 | BairdJoel Beatty |
Maintains | Outperform | $13 → $10 |
| 2025-03-25 | HC Wainwright & Co.Edward White |
Maintains | Buy | $15 → $16 |
| 2025-01-29 | Truist SecuritiesJoon Lee |
Initiates coverage on | Buy | $18 |
| 2025-01-24 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $15 |
| 2024-12-17 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $15 |
| 2024-12-16 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $15 |
| 2024-11-18 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $15 |
| 2024-10-31 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $15 |
| 2024-10-16 | OppenheimerAndreas Argyrides |
Initiates coverage on | Outperform | $26 |
| 2024-10-03 | WedbushLaura Chico |
Initiates coverage on | Outperform | $22 |
| 2024-10-02 | HC Wainwright & Co.Edward White |
Initiates coverage on | Buy | $15 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.14
- Market Cap
- $329.31 million
- 52-Week Range
- $2.71 – $6.42
- Average Volume
- 1.22 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.